The International stem cell companies directory
Welcome to stem-cell-companies.com

Suggest your link

Stem cell stocks

New link

Popular links


Nanotube suppliers
 
Stem cell companies search >>  [+] 
Optional: Searched words connector: And: Or:  

Friday, April 04, 2008

Home : Asia : Singapore

CellResearch Corporation Pte Ltd.  
Founded in 2002 by a group of dynamic clinician scientists and business angels, CellResearch Corp provides high quality primary cell strains, culture media and research service support to researchers and corporations the world over. With numerous cumulative years of professional expertise between our researchers, scientists and development team you can count on our technical and sales specialists to serve your needs while you concentrate on your research program.
  [Detailed Profile] - Country: Singapore

Home : Europe : United Kingdom

Epistem Ltd. (London Stock Exchange : EHP)  
Epistem is a biotechnology company applying its expertise in epithelial stem cells in the areas of oncology and gastrointestinal diseases as well as dermatological applications. Epistem has become recognised as a specialist in epithelial tissue and stem cell analyses. Our heritage is based on our expert science and know how in the field of epithelial tissue and adult epithelial stem cell biology.
  [Detailed Profile] - Country: United Kingdom - City: Manchester

UK Health Solutions  
UK Health Solutions is an organisation focusing on working towards developing health solutions that make a different. Our Cord Blood Stem Cells Storage service is our primary service offered to consumers, allowing parents-to-be to store their child's stem cells for future family use.
  [Detailed Profile] - Country: United Kingdom - City: Watford

Home : North America : Usa

AssureImmune LLC  
AssureImmune - a science based cell preservation leader - provides its clients with private adult stem cell collection and preservation medical services worldwide. The company specializes in collecting, testing, and banking an individual's own healthy adult stem cells from the peripheral blood of adults and from the cord blood of healthy new born infants.
  [Detailed Profile] - Country: USA - State/Region: Florida - City: Boca Raton

BioE Corporation  
BioE is a biomedical company whose mission is to commercialize human umbilical cord blood stem cells and the associated tools and technologies needed to develop life-enhancing therapeutics and pharmaceuticals via high-quality cellular research and drug discovery.
  [Detailed Profile] - Country: USA - State/Region: Minnesota - City: St. Paul

BrainStorm Cell Therapeutics Inc. (OTC BB : BCLI)  
BrainStorm (OTC BB: BCLI) is a company that is developing stem cell technologies to provide treatments for currently incurable neurodegenerative diseases. The Company is focused on developing adult stem cells taken from the patient's own bone marrow to treat diseases such as Parkinson's Disease (PD), Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease), and Spinal Cord Injury.
  [Detailed Profile] - Country: USA - State/Region: New York - City: New York

GlobalStem, Inc.  
Founded in March 2006, GlobalStem boasts a highly experienced, well-trained staff of stem cell experts. We are focused on creating standardized stem cell tools and providing contract services and technical support. Our products and services are tailored for the basic, applied, and clinical research communities. Located in Rockville, Maryland, close to Washington, DC, we are in a fast-paced, stimulating environment populated by world-class research institutions and companies.
  [Detailed Profile] - Country: USA - State/Region: Maryland - City: Rockville

Home : Other countries : Israel

Pluristem Therapeutics, Inc. (Nasdaq : PSTI)  
Pluristem Therapeutics, Inc. (NASDAQ: PSTI; DAX: PJT) is a bio-therapeutics Company dedicated to the commercialization of non-personalized (allogeneic) stem cell therapy products for the treatment of several severe degenerative, malignant and autoimmune disorders. The Company’s first planned product, PLX-I, targets a $3 billion annual market and is intended to resolve the global shortfall of matched tissue for bone marrow transplantation (BMT). Pluristem also believes its PLacental eXpanded (PLX) cells will be helpful for a variety of other indication, including as a help to patients afflicted with Peripheral Artery Disease (PAD) with critical limb ischemia (CLI).
  [Detailed Profile] - Country: Israel - City: Haifa


 Stem cell companies

Privacy   -   Disclaimer   -   Contact

Stem-cell-companies.com's button for your site